Brainlab Assembles Leading Experts from Across the Globe to Address Challenges in Radiation Oncology and Neurosurgery Cancer Treatments
Sixth International Conference of the Novalis Circle to Focus on Improving Clinical Outcomes of Brain and Spine RadiosurgeryMunich, February 18, 2016—On February 19th–20th, international experts in radiation oncology and neurosurgery will come together for the Sixth International Conference of the Novalis Circle in Munich sponsored by global medical technology leader, Brainlab. The conference will serve as a forum for a cross-functional community, including radiation oncology and neurosurgery, to strategically address timely topics surrounding brain and spine cancer disease management.
Conference participants will focus on stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) for brain and spine across multidisciplinary cancer teams. Practice-oriented presentations and panel discussions revolve around five main clinical treatment areas: brain metastases, primary benign tumors, vascular malformations, spine tumors and new radiosurgery technologies. A total of 30 SRS and SBRT experts will present, including Douglas Kondziolka, MD, Jörg-Christian Tonn, MD, Reinhard Wurm, MD, Mark H. Bilsky, MD, and Timothy D. Solberg, PhD.
“We have created a profoundly interesting, relevant agenda for this year’s Novalis Circle that promises to address the most pressing questions in the modern management of brain and spine radiosurgery,” said Stefan Vilsmeier, President and CEO of Brainlab. “With hundreds of accomplished clinicians and researchers working together, the conference opens new opportunities to fully harness the potential of SRS and SBRT technology as well as offering comprehensive and up-to-date treatment concepts now and in the future.”
The Novalis Circle is a worldwide network of clinicians dedicated to the advancement of radiosurgery. Novalis users represent the leading edge in the application of radiosurgery and their participation in the Novalis Circle represents their strong commitment to improving healthcare.
The Novalis Circle provides a communication and collaboration network for developing new ideas and to optimizing treatments that will continue to change the face of cancer treatment. The multidisciplinary, international conference focuses on the challenging aspects and usage of advanced brain and spine radiation therapy for treatment of brain metastases, primary benign tumors, vascular malformations, spine tumors and how new clinical paradigms offer value-based medicine and patient-centered healthcare.
For more information and a detailed agenda of the 6th International Conference of the Novalis Circle, please visit: www.novaliscircle2016.com.
Brainlab, headquartered in Munich, develops, manufactures and markets software-driven medical technology, enabling access to advanced, less invasive patient treatments.
Core products center on information-guided surgery, radiosurgery, precision radiation therapy, digital operating room integration, and information and knowledge exchange. Brainlab technology powers treatments in radiosurgery and radiotherapy as well as numerous surgical fields including neurosurgery, orthopedic, ENT, CMF, spine and trauma.
Privately held since its formation in Munich, Germany in 1989, Brainlab has more than 9,000 systems installed in about 100 countries. Brainlab employs 1,300 people in 19 offices worldwide, including 320 Research & Development engineers, who form a crucial part of the product development team.
To learn more, visit www.brainlab.com.